SCUBA

FLT1 — Fms related receptor tyrosine kinase 1

FLT1 belongs to a gene co-expression module in 5 of 28 SCUBA cell types. Each module groups genes that rise and fall together in that cell type; the genes it shares a module with are its closest co-expression partners there.

FLT1's module in each cell type

Cell typeModuleShares the module with
CD4⁺ T cellsT cell exhaustion
Exhaustion
CD247, CD38, CD59, GAN, IKBKB, LAG3, LRBA, PTMS +3 moreView in SCUBA
EndothelialVenous Endothelial Identity
Endothelial cell development
ACE, ADARB1, CDC42EP1, CLSTN1, EMCN, GALNT18, GPRC5B, GSN +11 moreView in SCUBA
MonocytesSPP1+ Inflammatory Macrophage
Inflammatory
DOCK4, DUSP4, GPR137B, IL7R, INHBA, MMP14, NECTIN2, SDC2 +6 moreView in SCUBA
NeutrophilsNF-κB Signaling
Inflammatory
ATP13A3, BMP6, DOCK4, DSE, HIVEP2, IRAK2, KIFC3, MAML2 +2 more
PericytesVascular Permeability
Migration & adhesion
ABI3, GALNT18, ITGA6, NQO1, PLVAP, PRKCH, TM4SF18View in SCUBA

About the gene

SynonymsFLT, VEGFR1
Chromosome13: 28300346-28495145
Predicted locationMembrane, Secreted
Essential geneNo
Protein classCancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins
Molecular functionDevelopmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase
Biological processAngiogenesis, Chemotaxis, Differentiation

Function

Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. Acts as a positive regulator of postnatal retinal hyaloid vessel regression (By similarity). May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells. Can promote endothelial cell proliferation, survival and angiogenesis in adulthood. Its function in promoting cell proliferation seems to be cell-type specific. Promotes PGF-mediated proliferation of endothelial cells, proliferation of some types of cancer cells, but does not promote proliferation of normal fibroblasts (in vitro). Has very high affinity for VEGFA and relatively low protein kinase activity; may function as a negative regulator of VEGFA signaling by limiting the amount of free VEGFA and preventing its binding to KDR. Modulates KDR signaling by forming heterodimers with KDR. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leading to activation of phosphatidylinositol kinase and the downstream signaling pathway. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Phosphorylates SRC and YES1, and may also phosphorylate CBL. Promotes phosphorylation of AKT1 at 'Ser-473'. Promotes phosphorylation of PTK2/FAK1. Phosphorylates PLCG. May function as decoy receptor for VEGFA. May function as decoy receptor for VEGFA. May function as decoy receptor for VEGFA. Has a truncated kinase domain; it increases phosphorylation of SRC at 'Tyr-418' by unknown means and promotes tumor cell invasion

Human Protein Atlas · Open Targets · UniProt

Gene annotation from the Human Protein Atlas and UniProt; see sources & licences.